Latest in Tumble Weight Loss
Sort by
216 items
-
FDA approves weight loss drug Zepbound for sleep apnea
Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said.NBC News - 1h -
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.CNBC - 1h -
Eli Lilly given US approval to treat sleep disorder with weight-loss drug
Regulatory go-ahead marks latest boost for drugmaker’s blockbuster anti-obesity franchiseFinancial Times - 1h -
F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition.The New York Times - 2h -
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.MarketWatch - 9h -
Novo Nordisk shares tumble as weight-loss drug trial data disappoints
Obesity drug CagriSema misses goal of 25% body weight reductionFinancial Times - 12h -
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.CNBC - 1d -
Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.The New York Times - 1d -
FDA warns companies over unapproved weight loss drug sales
The Food and Drug Administration (FDA) said Tuesday in a statement it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides, Swisschems, ...The Hill - 2d -
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.CNBC - 2d -
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
A Tennessee woman was accused of selling counterfeit versions of popular weight loss drugs including Ozempic. Experts say fakes have exploded in the U.S.NBC News - 3d -
These three new sports dramas punch above their weight
The sports movie, like any genre, can easily fall victim to overly familiar story beatsABC News - 3d -
These three new sports dramas punch above their weight
The sports movie, like any genre, can easily fall victim to overly familiar story beatsABC News - 4d -
Why the investor craze for Ozempic and rival weight-loss drugs may resume next year
Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts saidMarketWatch - 4d -
Oilers Defender Punches Above His Weight
Fists were flying in tonight's Edmonton Oilers versus Minnesota Wild game.Yahoo Sports - Dec. 13 -
In shift, RFK Jr. now says weight-loss drugs 'have a place'
His remarks come days before he holds confirmation meetings with GOP senators.ABC News - Dec. 12 -
Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.ABC News - Dec. 12 -
An NBA All-Star, a legendary father and the enormous weight of legacy
Beyond quietly dominating like Wilt and trying to lift a woebegone franchise to contention, Domantas Sabonis is chasing something even bigger: finishing an evolution his iconic dad began 40 years ago.ESPN - Dec. 12 -
What other conditions could weight-loss drugs treat?
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’sFinancial Times - Dec. 12 -
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline access to the popular treatment.CNBC - Dec. 11 -
GOP senators feel weight of Trump’s loyalty test on nominees
Weeks before even taking office, President-elect Trump is already sorely testing the loyalty of Republican senators by pushing an array of controversial nominees to key positions, putting enormous ...The Hill - Dec. 10 -
Some health experts warn against microdosing weight loss drugs
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some ...CBS News - Dec. 9 -
Comcast shares tumble as executive calls broadband 'intensely competitive'
Comcast shares fell Monday after its cable CEO called broadband "competitively intense," and expects to lose more than 100,000 customers in the fourth quarter.CNBC - Dec. 9 -
College basketball rankings: Kansas' upset loss at Missouri sends Jayhawks tumbling in Top 25 And 1
KU's loss to the Tigers was the second time this week it dropped a nonconference game on the roadCBS Sports - Dec. 9 -
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.CNBC - Dec. 8 -
Do weighted blankets help you sleep better? Here's what to know
Weighted blankets are a popular choice to warm up in cold weather, but research on their effectiveness is limitedABC News - Dec. 7 -
Rare whisky ‘bubble’ bursts as sales tumble
Value of rare malts sold at auction is down 40% this yearFinancial Times - Dec. 7 -
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two
People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.BBC News - Dec. 5 -
Frasers Group Tumbles After Guidance Cut
The U.K. sports-fashion retailer lost $540.4 million off its market value after it lowered expectations for its fiscal year, citing recent tough business conditions and weak consumer confidence.The Wall Street Journal - Dec. 5 -
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.CNBC - Dec. 5 -
Millions will have to wait up to 12 years for NHS weight-loss drug
Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.BBC News - Dec. 5 -
Foot Locker shares tumble as it issues gloomy holiday outlook, sees 'softness' at Nike
Foot Locker fell short of Wall Street expectations and cut its guidance after sales declined more than expected.CNBC - Dec. 4 -
Georgia Tumbles Deeper Into Crisis as Government Detains Opposition Figures
In a sign of a widening crackdown, security agents have searched the offices and homes of prominent activists and opposition leaders who are furious about the government’s position on Europe.The New York Times - Dec. 4 -
Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s ...MarketWatch - Dec. 4 -
Zepbound brings more weight loss than Wegovy: Drugmaker
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their ...The Hill - Dec. 4 -
Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy
Zepbound helped patients lose more weight than a major rival in a head-to-head trial.MarketWatch - Dec. 4 -
Peloton Strength+ Weight Lifting App: Details, Download, Price
I’m sick of it all and I need to be able to deadlift a body. Thankfully, Peloton has a brand-new app geared toward weights and strength training.Wired - Dec. 4 -
A rival weight loss drug to Wegovy helped people shed more pounds, study shows
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.NBC News - Dec. 4 -
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.CNBC - Dec. 4 -
Experts create controllable gastric balloon to aid weight loss
Device inflates before eating and contracts afterwards, simulating the effects of having a meal, say scientists. From weight loss jabs to vibrating pills , the obesity crisis has spawned myriad ...The Guardian - Dec. 3
